Guangdong Annuo Pharmaceutical

Guangdong Annuo Pharmaceutical is a comprehensive pharmaceutical enterprise based in Shantou, China, specializing in the research, development, and production of chemical drugs. Established in 2003, the company has developed a robust portfolio focusing on therapeutic areas such as cardiovascular health, anti-infectives, and metabolic disorders. Its key commercial products include amlodipine besylate for hypertension and various antibiotic formulations like cefixime and azithromycin. The company operates modern, GMP-certified manufacturing facilities and is listed on China's National Equities Exchange and Quotations (NEEQ). Annuo Pharmaceutical emphasizes technological innovation in drug delivery systems, particularly in sustained-release formulations.